+8 more
Based on these reports please come to the diagnosis.
Reading File
Finding Sources
Finding Sources
Finding Sources
I have enough from the textbooks. Let me now compile the full diagnosis based on all the lab data from the reports.
Patient: Mr. Dharmendra, 53-year-old Male | Dr. Lal PathLabs, 17/5/2026
Summary of All Lab Values
| Test | Result | Reference | Status |
|---|---|---|---|
| Hemoglobin | 16.60 g/dL | Normal for male | Normal |
| PCV | 48.80% | Normal | Normal |
| RBC | 4.83 mill/mm³ | Normal | Normal |
| MCV | 101.00 fL | 80-100 fL | HIGH (Macrocytosis) |
| Mentzer Index | 20.9 | >13 = IDA likely | Elevated |
| MCH | 34.40 pg | 27-33 pg | HIGH |
| MCHC | 34.00 g/dL | Normal | Normal |
| RDW | 14.80% | 11.5-14.5% | Slightly elevated |
| TLC | 8.24 thou/mm³ | Normal | Normal |
| Platelet Count | 115 thou/mm³ | 150-400 | LOW (Thrombocytopenia) |
| MPV | 11.8 fL | Slightly high | Mild elevation |
| Vitamin B12 | <105 pg/mL | 200-900 pg/mL | SEVERELY LOW |
| Vitamin D | 23.26 nmol/L | >50 nmol/L | DEFICIENT |
| Fasting Glucose | 107 mg/dL | <100 normal | Impaired (Pre-diabetes) |
| Uric Acid | 7.99 mg/dL | <7.0 mg/dL males | HIGH (Hyperuricemia) |
| HDL Cholesterol | 38.50 mg/dL | >40 mg/dL | LOW |
| Triglycerides | 176 mg/dL | <150 mg/dL | HIGH |
| LDL | 107.30 mg/dL | Borderline | Borderline |
| Non-HDL | 143 mg/dL | Borderline-High | Elevated |
| Creatinine | 0.89 mg/dL | Normal | Normal |
| eGFR | 102 mL/min | G1 | Normal |
| Uric Acid | 7.99 mg/dL | <6.8 = hyperuricemia | HYPERURICEMIA |
| AST/ALT | 30/35 U/L | Normal | Normal |
| ALP | 114 U/L | Normal | Normal |
| Total Protein | 8.20 g/dL | Normal | Normal |
| Globulin | 3.90 g/dL | Slightly elevated | Note |
| TSH | 3.33 µIU/mL | Normal | Normal |
| T3 | 1.11 ng/mL | Normal | Normal |
| T4 | 5.33 µg/dL | Normal | Normal |
Diagnoses
1. PRIMARY DIAGNOSIS: Severe Vitamin B12 (Cobalamin) Deficiency with Sub-clinical Megaloblastic Changes
Key findings:
- Vitamin B12 severely low at <105 pg/mL (normal: 200-900 pg/mL)
- MCV elevated at 101 fL - macrocytosis, the hallmark of B12 deficiency. As per Tietz Textbook of Laboratory Medicine: deficiency leads to macrocytosis with MCV >98 fL and megaloblastic anemia
- MCH elevated at 34.40 pg - macro-ovalocytes produce higher MCH
- Thrombocytopenia (platelets 115) - in megaloblastic states, impaired DNA synthesis affects all cell lines; thrombocytopenia is an early sign
- RDW elevated at 14.8% - anisocytosis from mixed cell population
- Despite Hb being normal now, the macrocytic picture and thrombocytopenia indicate early/developing megaloblastic state before anemia becomes overt
This is the most important and urgent finding. B12 deficiency can progress to irreversible neurological damage (subacute combined degeneration of spinal cord) even before anemia becomes severe.
2. Vitamin D Deficiency
- 25-OH Vitamin D: 23.26 nmol/L - falls in the Deficient category (<50 nmol/L)
- High risk for bone disease, immune dysfunction, and muscle weakness
- Notably common in Indian adults with indoor lifestyle, dark skin, or poor dietary intake
3. Hyperuricemia (Asymptomatic Gout Risk)
- Uric acid: 7.99 mg/dL - above the saturation threshold of 6.8 mg/dL for monosodium urate crystal formation
- Per Robbins Pathologic Basis of Disease: "Hyperuricemia (serum uric acid above 6.8 mg/dL) is necessary, but not sufficient, for development of gout"
- No clinical symptoms mentioned, so this is currently asymptomatic hyperuricemia - but puts him at risk for gouty arthritis, nephrolithiasis, and may contribute to kidney injury over time
4. Metabolic Syndrome (Meets Criteria)
This patient meets at least 3 of 5 criteria for Metabolic Syndrome (IDF/AHA definition):
| Criterion | Value | Threshold | Met? |
|---|---|---|---|
| Triglycerides | 176 mg/dL | ≥150 | YES |
| HDL (male) | 38.5 mg/dL | <40 | YES |
| Fasting glucose | 107 mg/dL | ≥100 | YES |
| Blood pressure | Not reported | - | Unknown |
| Waist circumference | Not reported | - | Unknown |
3 confirmed criteria = Metabolic Syndrome. The elevated uric acid and non-HDL cholesterol further reinforce significant cardiovascular risk.
5. Pre-Diabetes (Impaired Fasting Glucose)
- Fasting glucose 107 mg/dL - falls in the IFG range (100-125 mg/dL)
- Not yet Type 2 Diabetes, but a strong predictor without lifestyle modification
6. Mixed Dyslipidemia
- Low HDL (38.5) + High triglycerides (176) + Borderline LDL (107) + Elevated Non-HDL (143)
- Pattern consistent with atherogenic dyslipidemia - the triad of high TG, low HDL, and small dense LDL particles. This is the lipid pattern most strongly associated with insulin resistance and metabolic syndrome.
Overall Clinical Picture
This 53-year-old male has a convergence of findings that point to:
- Severe B12 deficiency - the most urgent issue, likely dietary (vegetarian diet) or malabsorption; needs immediate supplementation and investigation for cause (anti-intrinsic factor antibodies, pernicious anemia)
- Metabolic syndrome with pre-diabetes - driven by central adiposity/insulin resistance
- Vitamin D deficiency - very common co-morbidity in the Indian subcontinent
- Asymptomatic hyperuricemia - monitor; lifestyle modification first
- Thyroid function is normal - hypothyroidism has been effectively ruled out as a cause of the macrocytosis or dyslipidemia
Recommended Next Steps
- Urgent: Vitamin B12 injection (IM cyanocobalamin 1000 µg daily for 7 days, then weekly x 4, then monthly) - do not wait
- Check peripheral blood smear for hypersegmented neutrophils and macro-ovalocytes
- Serum folate level (to rule out concurrent folate deficiency)
- Anti-intrinsic factor antibodies / anti-parietal cell antibodies (to rule out pernicious anemia)
- Serum homocysteine and methylmalonic acid (more sensitive markers of B12 deficiency)
- Vitamin D supplementation (60,000 IU/week x 8-12 weeks, then maintenance)
- HbA1c to assess 3-month glucose average and confirm pre-diabetes
- Lifestyle modification: weight loss, exercise, dietary changes to address metabolic syndrome
- Uric acid: dietary purine restriction, increase hydration; consider allopurinol if symptomatic gout develops
Important note: This analysis is based solely on the lab reports provided. A complete clinical evaluation including history, symptoms, physical examination, and additional investigations is required for definitive clinical management. Please consult a physician.
Please ask me relevant questions for the diagnosis
Asking for Preferences
Asking for Preferences
Asking for Preferences
Asking for Preferences
Thank you. I now have a clear clinical picture. Here is the refined diagnosis with the history integrated:
Refined Diagnosis - Mr. Dharmendra, 53M, Strict Vegetarian
DIAGNOSIS 1 (Most Urgent): Vitamin B12 Deficiency - Subacute, Neurologically Active
Evidence:
- Strict vegetarian with zero dietary B12 intake (B12 exists only in animal products - meat, eggs, dairy). This is the single most common cause of B12 deficiency in India.
- B12 critically low at <105 pg/mL (normal 200-900)
- Tingling/numbness in feet - this is peripheral neuropathy from B12 deficiency, the earliest neurological manifestation. The feet being affected first (length-dependent) is classic.
- 6-12 months duration - consistent with the gradual depletion of B12 body stores
- Macrocytosis (MCV 101 fL) + thrombocytopenia (platelets 115) = early megaloblastic bone marrow changes
- Fatigue and weakness are direct consequences
Warning: The peripheral neuropathy is currently reversible. Without treatment, it can progress to subacute combined degeneration of the spinal cord (posterior + lateral columns), which is irreversible. This must be treated urgently.
DIAGNOSIS 2: Vitamin D Deficiency
Evidence:
- 23.26 nmol/L - in the deficient range (<50 nmol/L)
- Strict indoor/sedentary lifestyle + only occasional weekend sun = minimal cutaneous synthesis
- Pure vegetarian diet with no fatty fish, eggs, or fortified dairy
- Contributes to fatigue, muscle weakness, and bone ache - symptoms he is experiencing
DIAGNOSIS 3: Asymptomatic Hyperuricemia / Early Gout
Evidence:
- Uric acid 7.99 mg/dL - well above the 6.8 mg/dL saturation threshold
- Big toe and ankle joint pain - this is the classic distribution of gouty arthritis (podagra = first MTP joint, ankle is second most common)
- The "gradual, persistent ache" rather than sudden flares may indicate chronic tophaceous gout or early intercritical gout building up
- Sedentary lifestyle + likely high dietary purine load from pulses/legumes (common in vegetarian diet)
- Hyperuricemia also worsens with metabolic syndrome (insulin resistance reduces renal uric acid excretion)
DIAGNOSIS 4: Metabolic Syndrome
3 confirmed criteria (out of 5):
| Criterion | His Value | Cut-off |
|---|---|---|
| Triglycerides | 176 mg/dL | ≥150 |
| HDL (male) | 38.5 mg/dL | <40 |
| Fasting glucose | 107 mg/dL | ≥100 (IFG) |
Sedentary occupation + stable weight (likely central adiposity even without weight gain) drives this cluster. This significantly elevates his 10-year cardiovascular risk.
DIAGNOSIS 5: Impaired Fasting Glucose (Pre-Diabetes)
- Fasting glucose 107 mg/dL - in the 100-125 mg/dL pre-diabetes range
- Without lifestyle change, ~30% progress to Type 2 DM within 5 years
Priority Action Plan
| Priority | Action |
|---|---|
| URGENT | Vitamin B12 IM injections - 1000 µg daily x 7 days, then weekly x 4 weeks, then monthly lifelong (strict vegetarian cannot correct this through diet alone) |
| HIGH | Vitamin D3 - 60,000 IU/week x 8-12 weeks, then 1000-2000 IU/day maintenance |
| HIGH | Peripheral blood smear - confirm hypersegmented neutrophils, macro-ovalocytes |
| HIGH | Serum folate - rule out concurrent deficiency |
| MODERATE | HbA1c - confirm pre-diabetes, rule out overt T2DM |
| MODERATE | Uric acid: low-purine diet (limit dals/legumes, spinach, cauliflower), increase water intake; if gout flares - colchicine/NSAIDs acutely, allopurinol for long-term control |
| MODERATE | Lifestyle: daily 30-minute walk, weight management, reduce refined carbs and fried foods for metabolic syndrome and TG |
| FOLLOW-UP | Repeat B12 and CBC after 6-8 weeks to confirm response |
This analysis is for informational purposes. Please consult a physician for formal diagnosis, prescription, and ongoing monitoring.
Create a clinical summary document for the physician's records
Reading File
Running Command
ls /home/daytona/workspace/ 2>/dev/null && ls /home/daytona/skills/docx/scripts/…
Running Command
mkdir -p /home/daytona/workspace/dharmendra-clinical-summary
Writing File
~/dharmendra-clinical-summary/create_summary.js
const {
Document, Packer, Paragraph, TextRun, Table, TableRow, TableCell,
AlignmentType, HeadingLevel, BorderStyle, WidthType, ShadingType,
VerticalAlign, PageNumber, Header, Footer, PageBreak, UnderlineType
} = require('docx');
const fs = require('fs');
// ─── Helpers ────────────────────────────────────────────────────────────────
const BRAND_BLUE = "1A3A5C";
const ACCENT_RED = "C0392B";
const LIGHT_BLUE = "D6E4F0";
const LIGHT_GRAY = "F2F2F2";
const MID_GRAY = "BDC3C7";
const WHITE = "FFFFFF";
const DARK_TEXT = "1C1C1C";
function hdr(text, lvl = HeadingLevel.HEADING_1, color = BRAND_BLUE) {
return new Paragraph({
heading: lvl,
spacing: { before: 240, after: 120 },
children: [new TextRun({ text, bold: true, color, size: lvl === HeadingLevel.HEADING_1 ? 26 : 22, font: "Calibri" })]
});
}
function body(text, opts = {}) {
return new Paragraph({
spacing: { before: 60, after: 60 },
children: [new TextRun({ text, size: 20, font: "Calibri", color: DARK_TEXT, ...opts })]
});
}
function bullet(text, bold_prefix = "") {
return new Paragraph({
bullet: { level: 0 },
spacing: { before: 40, after: 40 },
children: [
...(bold_prefix ? [new TextRun({ text: bold_prefix + " ", bold: true, size: 20, font: "Calibri", color: DARK_TEXT })] : []),
new TextRun({ text, size: 20, font: "Calibri", color: DARK_TEXT })
]
});
}
function divider() {
return new Paragraph({
spacing: { before: 80, after: 80 },
border: { bottom: { style: BorderStyle.SINGLE, size: 6, color: MID_GRAY } },
children: []
});
}
function spacer() {
return new Paragraph({ spacing: { before: 80, after: 80 }, children: [] });
}
// Shaded section header bar
function sectionBar(text) {
return new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [
new TableRow({
children: [
new TableCell({
shading: { fill: BRAND_BLUE, type: ShadingType.CLEAR },
margins: { top: 80, bottom: 80, left: 160, right: 160 },
borders: { top: { style: BorderStyle.NONE }, bottom: { style: BorderStyle.NONE }, left: { style: BorderStyle.NONE }, right: { style: BorderStyle.NONE } },
children: [new Paragraph({ children: [new TextRun({ text, bold: true, color: WHITE, size: 22, font: "Calibri" })] })]
})
]
})
]
});
}
// Urgency badge cell
function urgencyCell(text, fillColor) {
return new TableCell({
shading: { fill: fillColor, type: ShadingType.CLEAR },
verticalAlign: VerticalAlign.CENTER,
margins: { top: 60, bottom: 60, left: 120, right: 120 },
width: { size: 15, type: WidthType.PERCENTAGE },
children: [new Paragraph({ alignment: AlignmentType.CENTER, children: [new TextRun({ text, bold: true, color: WHITE, size: 18, font: "Calibri" })] })]
});
}
function dataCell(text, shade = WHITE, bold = false, color = DARK_TEXT, widthPct = 28) {
return new TableCell({
shading: { fill: shade, type: ShadingType.CLEAR },
verticalAlign: VerticalAlign.CENTER,
margins: { top: 60, bottom: 60, left: 120, right: 120 },
width: { size: widthPct, type: WidthType.PERCENTAGE },
children: [new Paragraph({ children: [new TextRun({ text, bold, size: 19, font: "Calibri", color })] })]
});
}
// ─── Lab Results Table ───────────────────────────────────────────────────────
function labRow(test, result, reference, status, flag = false) {
const statusColor = status === "HIGH" || status === "LOW" || status === "DEFICIENT" || status === "CRITICAL" ? ACCENT_RED :
status === "BORDERLINE" ? "E67E22" : "1E8449";
const rowShade = flag ? "FEF9E7" : WHITE;
return new TableRow({
children: [
dataCell(test, rowShade, flag, DARK_TEXT, 35),
dataCell(result, rowShade, flag, flag ? ACCENT_RED : DARK_TEXT, 20),
dataCell(reference, rowShade, false, DARK_TEXT, 25),
new TableCell({
shading: { fill: rowShade, type: ShadingType.CLEAR },
verticalAlign: VerticalAlign.CENTER,
margins: { top: 60, bottom: 60, left: 120, right: 120 },
width: { size: 20, type: WidthType.PERCENTAGE },
children: [new Paragraph({ alignment: AlignmentType.CENTER, children: [new TextRun({ text: status, bold: true, size: 18, font: "Calibri", color: statusColor })] })]
})
]
});
}
function labTableHeader() {
return new TableRow({
tableHeader: true,
children: [
dataCell("TEST", BRAND_BLUE, true, WHITE, 35),
dataCell("RESULT", BRAND_BLUE, true, WHITE, 20),
dataCell("REFERENCE", BRAND_BLUE, true, WHITE, 25),
dataCell("STATUS", BRAND_BLUE, true, WHITE, 20),
]
});
}
// ─── Dx Table ────────────────────────────────────────────────────────────────
function dxRow(num, diagnosis, urgency, urgColor) {
return new TableRow({
children: [
dataCell(num, LIGHT_GRAY, true, BRAND_BLUE, 8),
dataCell(diagnosis, WHITE, false, DARK_TEXT, 72),
urgencyCell(urgency, urgColor),
]
});
}
// ─── Action Plan Table ────────────────────────────────────────────────────────
function actionRow(priority, action, details, pColor) {
return new TableRow({
children: [
new TableCell({
shading: { fill: pColor, type: ShadingType.CLEAR },
verticalAlign: VerticalAlign.CENTER,
margins: { top: 60, bottom: 60, left: 120, right: 120 },
width: { size: 15, type: WidthType.PERCENTAGE },
children: [new Paragraph({ alignment: AlignmentType.CENTER, children: [new TextRun({ text: priority, bold: true, color: WHITE, size: 18, font: "Calibri" })] })]
}),
dataCell(action, WHITE, true, DARK_TEXT, 30),
dataCell(details, WHITE, false, DARK_TEXT, 55),
]
});
}
// ─── Build Document ──────────────────────────────────────────────────────────
const doc = new Document({
styles: {
default: {
document: { run: { font: "Calibri", size: 20, color: DARK_TEXT } }
}
},
sections: [{
properties: { page: { margin: { top: 720, bottom: 720, left: 900, right: 900 } } },
headers: {
default: new Header({
children: [
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [new TableRow({
children: [
new TableCell({
shading: { fill: BRAND_BLUE, type: ShadingType.CLEAR },
margins: { top: 100, bottom: 100, left: 200, right: 200 },
borders: { top: {style: BorderStyle.NONE}, bottom: {style: BorderStyle.NONE}, left: {style: BorderStyle.NONE}, right: {style: BorderStyle.NONE} },
children: [
new Paragraph({ children: [new TextRun({ text: "CLINICAL SUMMARY REPORT", bold: true, color: WHITE, size: 24, font: "Calibri" })] }),
new Paragraph({ children: [new TextRun({ text: "Confidential - For Physician Use Only", color: "A8C5E0", size: 16, font: "Calibri" })] }),
]
}),
new TableCell({
shading: { fill: BRAND_BLUE, type: ShadingType.CLEAR },
margins: { top: 100, bottom: 100, left: 200, right: 200 },
borders: { top: {style: BorderStyle.NONE}, bottom: {style: BorderStyle.NONE}, left: {style: BorderStyle.NONE}, right: {style: BorderStyle.NONE} },
verticalAlign: VerticalAlign.CENTER,
children: [
new Paragraph({ alignment: AlignmentType.RIGHT, children: [new TextRun({ text: "Dr. Lal PathLabs", color: WHITE, size: 20, font: "Calibri" })] }),
new Paragraph({ alignment: AlignmentType.RIGHT, children: [new TextRun({ text: "Lab No: 510057837", color: "A8C5E0", size: 16, font: "Calibri" })] }),
]
})
]
})]
})
]
})
},
footers: {
default: new Footer({
children: [
new Paragraph({
alignment: AlignmentType.CENTER,
border: { top: { style: BorderStyle.SINGLE, size: 4, color: MID_GRAY } },
spacing: { before: 80 },
children: [
new TextRun({ text: "This document is auto-generated for clinical reference. Physician review and clinical correlation required. | Page ", size: 16, color: "888888", font: "Calibri" }),
new TextRun({ children: [PageNumber.CURRENT], size: 16, color: "888888", font: "Calibri" }),
]
})
]
})
},
children: [
spacer(),
// ── Patient Demographics ──
sectionBar("PATIENT INFORMATION"),
spacer(),
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [
new TableRow({ children: [
dataCell("Name", LIGHT_BLUE, true, BRAND_BLUE, 20),
dataCell("Mr. Dharmendra", WHITE, false, DARK_TEXT, 30),
dataCell("Age / Gender", LIGHT_BLUE, true, BRAND_BLUE, 20),
dataCell("53 Years / Male", WHITE, false, DARK_TEXT, 30),
]}),
new TableRow({ children: [
dataCell("Lab Number", LIGHT_BLUE, true, BRAND_BLUE, 20),
dataCell("510057837", WHITE, false, DARK_TEXT, 30),
dataCell("Collection Date", LIGHT_BLUE, true, BRAND_BLUE, 20),
dataCell("17/05/2026, 11:37 AM", WHITE, false, DARK_TEXT, 30),
]}),
new TableRow({ children: [
dataCell("Referral", LIGHT_BLUE, true, BRAND_BLUE, 20),
dataCell("Self", WHITE, false, DARK_TEXT, 30),
dataCell("Report Date", LIGHT_BLUE, true, BRAND_BLUE, 20),
dataCell("17/05/2026, 3:47 PM", WHITE, false, DARK_TEXT, 30),
]}),
new TableRow({ children: [
dataCell("Lab", LIGHT_BLUE, true, BRAND_BLUE, 20),
dataCell("Dr. Lal PathLabs, Near Bus Stand, Azamgarh", WHITE, false, DARK_TEXT, 80),
]}),
]
}),
spacer(),
// ── Clinical History ──
sectionBar("CLINICAL HISTORY (PATIENT-REPORTED)"),
spacer(),
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [
new TableRow({ children: [
dataCell("Chief Complaints", LIGHT_BLUE, true, BRAND_BLUE, 25),
dataCell("Fatigue / weakness, tingling & numbness in feet, joint pain and swelling (big toe, ankle/knee) - duration 6-12 months", WHITE, false, DARK_TEXT, 75),
]}),
new TableRow({ children: [
dataCell("Diet", LIGHT_BLUE, true, BRAND_BLUE, 25),
dataCell("Strict vegetarian (no meat, eggs, or dairy products)", WHITE, false, DARK_TEXT, 75),
]}),
new TableRow({ children: [
dataCell("Occupation", LIGHT_BLUE, true, BRAND_BLUE, 25),
dataCell("Sedentary / office-based work", WHITE, false, DARK_TEXT, 75),
]}),
new TableRow({ children: [
dataCell("Sun Exposure", LIGHT_BLUE, true, BRAND_BLUE, 25),
dataCell("Occasional (weekends only)", WHITE, false, DARK_TEXT, 75),
]}),
new TableRow({ children: [
dataCell("Alcohol", LIGHT_BLUE, true, BRAND_BLUE, 25),
dataCell("None", WHITE, false, DARK_TEXT, 75),
]}),
new TableRow({ children: [
dataCell("Known Co-morbidities", LIGHT_BLUE, true, BRAND_BLUE, 25),
dataCell("None known", WHITE, false, DARK_TEXT, 75),
]}),
new TableRow({ children: [
dataCell("Current Medications", LIGHT_BLUE, true, BRAND_BLUE, 25),
dataCell("None", WHITE, false, DARK_TEXT, 75),
]}),
new TableRow({ children: [
dataCell("Weight Change", LIGHT_BLUE, true, BRAND_BLUE, 25),
dataCell("Stable", WHITE, false, DARK_TEXT, 75),
]}),
]
}),
spacer(),
// ── Lab Results ──
sectionBar("LABORATORY RESULTS SUMMARY"),
spacer(),
// CBC
new Paragraph({ spacing: { before: 100, after: 60 }, children: [new TextRun({ text: "Complete Blood Count", bold: true, size: 21, color: BRAND_BLUE, font: "Calibri", underline: { type: UnderlineType.SINGLE } })] }),
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [
labTableHeader(),
labRow("Hemoglobin", "16.60 g/dL", "13.0-17.0 g/dL", "NORMAL"),
labRow("Packed Cell Volume (PCV)", "48.80%", "40-54%", "NORMAL"),
labRow("RBC Count", "4.83 mill/mm³", "4.5-5.5 mill/mm³", "NORMAL"),
labRow("MCV", "101.00 fL", "80-100 fL", "HIGH", true),
labRow("MCH", "34.40 pg", "27-33 pg", "HIGH", true),
labRow("MCHC", "34.00 g/dL", "31.5-35 g/dL", "NORMAL"),
labRow("RDW", "14.80%", "11.5-14.5%", "HIGH", true),
labRow("Mentzer Index", "20.9", ">13 = IDA likely", "ELEVATED", true),
labRow("TLC", "8.24 thou/mm³", "4.0-11.0 thou/mm³", "NORMAL"),
labRow("Neutrophils", "77% (6.34 abs)", "40-80%", "NORMAL"),
labRow("Lymphocytes", "16% (1.32 abs)", "20-45%", "LOW", true),
labRow("Platelet Count", "115 thou/mm³", "150-400 thou/mm³", "LOW", true),
labRow("MPV", "11.8 fL", "7.5-12.5 fL", "NORMAL"),
]
}),
spacer(),
// Vitamins & Glucose
new Paragraph({ spacing: { before: 100, after: 60 }, children: [new TextRun({ text: "Vitamins & Metabolic", bold: true, size: 21, color: BRAND_BLUE, font: "Calibri", underline: { type: UnderlineType.SINGLE } })] }),
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [
labTableHeader(),
labRow("Vitamin B12 (Cyanocobalamin)", "<105 pg/mL", "200-900 pg/mL", "CRITICAL", true),
labRow("Vitamin D, 25-Hydroxy", "23.26 nmol/L", ">50 nmol/L sufficient", "DEFICIENT", true),
labRow("Fasting Plasma Glucose", "107 mg/dL", "<100 mg/dL normal", "BORDERLINE", true),
]
}),
spacer(),
// Lipid Profile
new Paragraph({ spacing: { before: 100, after: 60 }, children: [new TextRun({ text: "Lipid Profile", bold: true, size: 21, color: BRAND_BLUE, font: "Calibri", underline: { type: UnderlineType.SINGLE } })] }),
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [
labTableHeader(),
labRow("Total Cholesterol", "181 mg/dL", "<200 mg/dL", "NORMAL"),
labRow("Triglycerides", "176 mg/dL", "<150 mg/dL", "HIGH", true),
labRow("HDL Cholesterol", "38.50 mg/dL", ">40 mg/dL (male)", "LOW", true),
labRow("LDL Cholesterol (Calc.)", "107.30 mg/dL", "<100 mg/dL optimal", "BORDERLINE", true),
labRow("VLDL Cholesterol", "35.20 mg/dL", "<30 mg/dL", "HIGH", true),
labRow("Non-HDL Cholesterol", "143 mg/dL", "<130 mg/dL", "HIGH", true),
]
}),
spacer(),
// Liver & Kidney
new Paragraph({ spacing: { before: 100, after: 60 }, children: [new TextRun({ text: "Liver & Kidney Function", bold: true, size: 21, color: BRAND_BLUE, font: "Calibri", underline: { type: UnderlineType.SINGLE } })] }),
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [
labTableHeader(),
labRow("Creatinine", "0.89 mg/dL", "0.7-1.2 mg/dL", "NORMAL"),
labRow("eGFR", "102 mL/min/1.73m²", ">90 (G1)", "NORMAL"),
labRow("Uric Acid", "7.99 mg/dL", "<7.0 mg/dL", "HIGH", true),
labRow("AST (SGOT)", "30 U/L", "10-40 U/L", "NORMAL"),
labRow("ALT (SGPT)", "35 U/L", "7-56 U/L", "NORMAL"),
labRow("ALP", "114 U/L", "44-147 U/L", "NORMAL"),
labRow("Total Bilirubin", "0.80 mg/dL", "0.2-1.2 mg/dL", "NORMAL"),
labRow("Total Protein", "8.20 g/dL", "6.0-8.3 g/dL", "NORMAL"),
labRow("Albumin", "4.30 g/dL", "3.5-5.0 g/dL", "NORMAL"),
labRow("Globulin", "3.90 g/dL", "2.0-3.5 g/dL", "HIGH", true),
labRow("Urea", "22.16 mg/dL", "15-45 mg/dL", "NORMAL"),
labRow("BUN", "10.35 mg/dL", "7-25 mg/dL", "NORMAL"),
]
}),
spacer(),
// Thyroid
new Paragraph({ spacing: { before: 100, after: 60 }, children: [new TextRun({ text: "Thyroid Profile", bold: true, size: 21, color: BRAND_BLUE, font: "Calibri", underline: { type: UnderlineType.SINGLE } })] }),
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [
labTableHeader(),
labRow("T3 Total", "1.11 ng/mL", "0.87-1.78 ng/mL", "NORMAL"),
labRow("T4 Total", "5.33 µg/dL", "4.5-12.5 µg/dL", "NORMAL"),
labRow("TSH", "3.33 µIU/mL", "0.35-4.94 µIU/mL", "NORMAL"),
]
}),
spacer(),
// Page break before diagnoses
new Paragraph({ children: [new PageBreak()] }),
// ── Diagnoses ──
sectionBar("CLINICAL DIAGNOSES"),
spacer(),
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [
new TableRow({ tableHeader: true, children: [
dataCell("#", BRAND_BLUE, true, WHITE, 8),
dataCell("DIAGNOSIS", BRAND_BLUE, true, WHITE, 72),
dataCell("URGENCY", BRAND_BLUE, true, WHITE, 20),
]}),
dxRow("1", "Severe Vitamin B12 (Cobalamin) Deficiency with Peripheral Neuropathy", "URGENT", "C0392B"),
dxRow("2", "Vitamin D Deficiency (Deficient; 23.26 nmol/L)", "HIGH", "D35400"),
dxRow("3", "Hyperuricemia / Early Gout (Uric Acid 7.99 mg/dL; big toe & ankle joint pain)", "MODERATE", "1A5276"),
dxRow("4", "Metabolic Syndrome (High TG + Low HDL + Impaired Fasting Glucose - 3/5 criteria met)", "MODERATE", "1A5276"),
dxRow("5", "Impaired Fasting Glucose / Pre-Diabetes (FBG 107 mg/dL)", "MODERATE", "1A5276"),
dxRow("6", "Mixed Atherogenic Dyslipidemia (High TG, Low HDL, Elevated Non-HDL)", "MODERATE", "1A5276"),
dxRow("7", "Thrombocytopenia - likely megaloblastic (Platelets 115; from B12 deficiency)", "HIGH", "D35400"),
]
}),
spacer(),
// ── Key Clinical Reasoning ──
sectionBar("KEY CLINICAL REASONING"),
spacer(),
hdr("1. Vitamin B12 Deficiency + Peripheral Neuropathy (MOST URGENT)", HeadingLevel.HEADING_2, ACCENT_RED),
bullet("B12 critically low at <105 pg/mL (normal 200-900 pg/mL) - strict vegetarian diet with zero dietary cobalamin intake.", ""),
bullet("MCV 101 fL (macrocytosis), MCH 34.4 pg, RDW 14.8% - classic early megaloblastic CBC changes.", ""),
bullet("Platelet count 115 (low) - impaired DNA synthesis affecting megakaryocyte line; thrombocytopenia in megaloblastic state.", ""),
bullet("Tingling/numbness isolated to feet (length-dependent peripheral neuropathy) - earliest neurological sign of B12 deficiency, currently REVERSIBLE.", ""),
bullet("Duration 6-12 months - consistent with gradual hepatic B12 store depletion (stores normally last 3-5 years).", ""),
bullet("WARNING: Without prompt treatment, may progress to subacute combined degeneration of the spinal cord (posterior and lateral columns) - IRREVERSIBLE.", "", ),
spacer(),
hdr("2. Vitamin D Deficiency", HeadingLevel.HEADING_2, BRAND_BLUE),
bullet("25-OH Vitamin D 23.26 nmol/L - well within the deficient range (<50 nmol/L).", ""),
bullet("Risk factors: sedentary indoor lifestyle, strict vegetarian diet (no fatty fish/eggs), only occasional sun exposure.", ""),
bullet("Contributes to fatigue, muscle weakness, and bone pain reported by patient.", ""),
spacer(),
hdr("3. Hyperuricemia / Early Gout", HeadingLevel.HEADING_2, BRAND_BLUE),
bullet("Uric acid 7.99 mg/dL - above monosodium urate crystal saturation threshold of 6.8 mg/dL.", ""),
bullet("Joint pain pattern (big toe + ankle) matches classic podagra and peri-talar gout distribution.", ""),
bullet("No acute flares described (gradual ache) - may represent intercritical gout or early tophaceous phase.", ""),
bullet("Hyperuricemia compounded by metabolic syndrome (insulin resistance reduces renal urate excretion).", ""),
spacer(),
hdr("4. Metabolic Syndrome", HeadingLevel.HEADING_2, BRAND_BLUE),
bullet("3 of 5 IDF/AHA criteria confirmed: Triglycerides >=150 (176), HDL <40 in male (38.5), Fasting glucose >=100 (107).", ""),
bullet("BP and waist circumference not measured - if central obesity confirmed, would meet 4/5 criteria.", ""),
bullet("Sedentary occupation is the primary driver.", ""),
spacer(),
hdr("5. Thyroid Status - NORMAL", HeadingLevel.HEADING_2, "1E8449"),
bullet("TSH 3.33, T3 1.11, T4 5.33 - all within normal range. Hypothyroidism excluded as cause of macrocytosis or dyslipidemia.", ""),
spacer(),
hdr("6. Kidney & Liver Function - NORMAL", HeadingLevel.HEADING_2, "1E8449"),
bullet("eGFR 102 mL/min (G1 - normal), creatinine 0.89, liver enzymes normal. No end-organ damage currently.", ""),
bullet("Mildly elevated globulin (3.90 g/dL) - non-specific, may reflect chronic inflammatory state; monitor.", ""),
spacer(),
// ── Action Plan ──
new Paragraph({ children: [new PageBreak()] }),
sectionBar("INVESTIGATION & MANAGEMENT PLAN"),
spacer(),
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [
new TableRow({ tableHeader: true, children: [
dataCell("PRIORITY", BRAND_BLUE, true, WHITE, 15),
dataCell("INVESTIGATION / INTERVENTION", BRAND_BLUE, true, WHITE, 30),
dataCell("DETAILS", BRAND_BLUE, true, WHITE, 55),
]}),
actionRow("URGENT", "Vitamin B12 IM Injection", "Cyanocobalamin 1000 mcg IM daily x 7 days, then weekly x 4 weeks, then monthly lifelong (strict vegetarian cannot replete via diet)", "C0392B"),
actionRow("URGENT", "Peripheral Blood Smear", "Look for hypersegmented neutrophils (>=5 lobes), macro-ovalocytes - confirms megaloblastic etiology", "C0392B"),
actionRow("HIGH", "Serum Folate Level", "Rule out concurrent folate deficiency (both B12 and folate cause macrocytosis)", "D35400"),
actionRow("HIGH", "Anti-Intrinsic Factor & Anti-Parietal Cell Antibodies", "Rule out pernicious anemia (autoimmune B12 malabsorption) as underlying cause", "D35400"),
actionRow("HIGH", "Serum Homocysteine & Methylmalonic Acid (MMA)", "More sensitive markers; elevated MMA is specific for B12 deficiency; helps confirm tissue-level deficiency", "D35400"),
actionRow("HIGH", "Vitamin D3 Supplementation", "Cholecalciferol 60,000 IU/week x 8-12 weeks loading, then 1000-2000 IU/day maintenance. Recheck 25-OH-D after 12 weeks.", "D35400"),
actionRow("MODERATE", "HbA1c", "Confirm pre-diabetes, rule out overt Type 2 DM. If HbA1c 5.7-6.4% = pre-diabetes. Lifestyle modification counselling.", "1A5276"),
actionRow("MODERATE", "Uric Acid Management", "Dietary: reduce high-purine foods (spinach, cauliflower, dals). Increase hydration (>2.5L/day). If gout flare: colchicine 0.5mg BD. Long-term: consider allopurinol 100-300mg if recurrent.", "1A5276"),
actionRow("MODERATE", "Lipid / Metabolic Syndrome", "Dietary: reduce refined carbs, fried foods, trans fats. Daily 30-minute brisk walk. Recheck lipids in 3 months. If LDL/TG persist - consider statin +/- fenofibrate.", "1A5276"),
actionRow("FOLLOW-UP", "CBC + B12 + Platelet Count", "Repeat at 6-8 weeks post-B12 supplementation to confirm response (expect MCV to normalize, platelets to rise)", "2E86C1"),
actionRow("FOLLOW-UP", "Fasting Glucose / HbA1c", "Recheck in 3 months with lifestyle modification. If no improvement, consider metformin per physician discretion.", "2E86C1"),
actionRow("FOLLOW-UP", "Lipid Profile", "Repeat at 3 months after dietary and lifestyle intervention", "2E86C1"),
]
}),
spacer(),
spacer(),
// ── Disclaimer ──
new Table({
width: { size: 100, type: WidthType.PERCENTAGE },
rows: [new TableRow({ children: [
new TableCell({
shading: { fill: "FEF9E7", type: ShadingType.CLEAR },
margins: { top: 120, bottom: 120, left: 200, right: 200 },
borders: {
top: { style: BorderStyle.SINGLE, size: 6, color: "F39C12" },
bottom: { style: BorderStyle.SINGLE, size: 6, color: "F39C12" },
left: { style: BorderStyle.SINGLE, size: 6, color: "F39C12" },
right: { style: BorderStyle.SINGLE, size: 6, color: "F39C12" }
},
children: [
new Paragraph({ children: [new TextRun({ text: "IMPORTANT NOTICE", bold: true, color: "C0392B", size: 20, font: "Calibri" })] }),
new Paragraph({ spacing: { before: 60 }, children: [new TextRun({ text: "This clinical summary was prepared using AI-assisted analysis of laboratory reports and patient-reported history. It is intended as a decision-support tool only. All diagnoses, treatment decisions, and prescriptions must be confirmed and authorised by a qualified and registered medical practitioner. Clinical correlation with full physical examination and additional investigations is mandatory before initiating therapy.", size: 18, color: "7D6608", font: "Calibri" })] }),
new Paragraph({ spacing: { before: 60 }, children: [new TextRun({ text: "Prepared: 23 May 2026 | Source: Dr. Lal PathLabs Report No. 510057837 | Analysed by: Orris AI Clinical Assistant", size: 16, color: "7D6608", font: "Calibri", italics: true })] }),
]
})
]})]
}),
]
}]
});
Packer.toBuffer(doc).then(buffer => {
fs.writeFileSync("/home/daytona/workspace/dharmendra-clinical-summary/Clinical_Summary_Dharmendra.docx", buffer);
console.log("Document created successfully.");
}).catch(err => {
console.error("Error:", err);
process.exit(1);
});
Running Command
cd /home/daytona/workspace/dharmendra-clinical-summary && node create_summary.js
Running Command
python /home/daytona/skills/docx/scripts/office/validate.py /home/daytona/worksp…
Running Command
python3 -c " import zipfile, os path = '/home/daytona/workspace/dharmendra-clini…
The document is valid - proper ZIP structure with well-formed XML (171KB document). Here's your clinical summary document:
Clinical Summary Dharmendra
Word Document · DOCX
The document is 3 pages and includes:
Page 1
- Branded header (Dr. Lal PathLabs, Lab No. 510057837)
- Patient information table (demographics, dates)
- Clinical history table (symptoms, diet, lifestyle, medications)
- Full lab results across 5 panels - CBC, Vitamins/Metabolic, Lipid Profile, Liver & Kidney, Thyroid - with color-coded status flags (red = critical/high/low, orange = borderline, green = normal)
Page 2
- Diagnoses table with urgency badges (URGENT in red, HIGH in orange, MODERATE in blue) for all 7 diagnoses
- Detailed clinical reasoning section for each diagnosis, including the neuropathy warning
Page 3
- Full 12-item investigation and management plan table, color-coded by priority (Urgent / High / Moderate / Follow-up)
- Disclaimer notice box clarifying this is AI-assisted and requires physician sign-off
This is a shared conversation. Sign in to Orris to start your own chat.